Tamoxifen induces fatty liver disease in breast cancer through the MAPK8/FoxO pathway

BACKGROUND: Prevention of metabolic complications of long‐term adjuvant endocrine therapy in breast cancers remained a challenge. We aimed to investigate the molecular mechanism in the development of tamoxifen (TAM)‐induced fatty liver in both estrogen receptor (ER)‐positive and ER‐negative breast c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Transl Med
Main Authors: Gong, Liuyun, Tang, Hanmin, Luo, Zhenzhen, Sun, Xiao, Tan, Xinyue, Xie, Lina, Lei, Yutiantian, Cai, Mengjiao, He, Chenchen, Ma, Jinlu, Han, Suxia
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7240857/
https://ncbi.nlm.nih.gov/pubmed/32508033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ctm2.5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados